PAHC(Phibro Animal Health Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-06-30 | FY 截至 2023-06-30 | FY 截至 2024-06-30 | FY 截至 2025-06-30 | FY 截至 2026-06-30 |
|---|---|---|---|---|---|
| 营业收入 | $942.26M | $977.89M | $1.02B | $1.30B | $1.52B |
| 毛利润 | $285.40M | $298.24M | $313.09M | $399.94M | $512.51M |
| 营业利润 | $78.99M | $71.85M | $53.31M | $110.47M | $194.40M |
| 净利润 | $49.17M | $32.61M | $2.42M | $48.26M | $99.72M |
| 经营现金流 | $31.65M | $13.31M | $87.59M | $80.12M | $68.95M |
| 自由现金流 | −$5.39M | −$38.48M | $46.36M | $41.83M | $9.87M |
| 摊薄每股收益 | $1.21 | $0.81 | $0.06 | $1.19 | $2.43 |